The phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)–protein kinase B (AKT)–mammalian target of rapamycin (mTOR) signalling pathway, which is inappropriately activated in many cancers, plays a central role in the genesis and progression of NET. The gene discussed is MTOR; the disease is cancer.